Literature DB >> 8374958

Antigen presentation by the B cell antigen receptor is driven by the alpha/beta sheath and occurs independently of its cytoplasmic tyrosines.

K J Patel1, M S Neuberger.   

Abstract

Membrane immunoglobulin functions to internalize bound antigen for its subsequent processing and presentation to T cells. Although the five immunoglobulin isotypes exhibit considerable differences in their cytoplasmic domains, we show by use of matched B lymphoma transfectants that all isotypes manifest a similar high efficacy in antigen presentation. Experiments using mutant receptors reveal that this efficacy can be ascribed to the alpha/beta sheath of the receptor, where presentation correlates with internalization of polyvalent antigen. Efficient presentation is restored to a sheathless antigen receptor by providing it with only the cytoplasmic domain of the beta sheath polypeptide. This restoration of activity does not depend on the tyrosine residues in the beta cytoplasmic tail, implying that antigen receptor-mediated presentation can occur by a pathway distinct from that used by the Fc receptor Fc gamma RIII.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374958     DOI: 10.1016/0092-8674(93)90473-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  18 in total

Review 1.  Models of signal transduction through the B-cell antigen receptor.

Authors:  Roland Geisberger; Reto Crameri; Gernot Achatz
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

2.  Independent trafficking of Ig-alpha/Ig-beta and mu-heavy chain is facilitated by dissociation of the B cell antigen receptor complex.

Authors:  Jin-Hyang Kim; Lorraine Cramer; Heather Mueller; Bridget Wilson; Barbara J Vilen
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

3.  Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction.

Authors:  V R Aluvihare; A A Khamlichi; G T Williams; L Adorini; M S Neuberger
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

Review 4.  Mechanisms of central tolerance for B cells.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2017-04-03       Impact factor: 53.106

5.  Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes.

Authors:  R N Mitchell; K A Barnes; S A Grupp; M Sanchez; Z Misulovin; M C Nussenzweig; A K Abbas
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

6.  The alpha/beta sheath and its cytoplasmic tyrosines are required for signaling by the B-cell antigen receptor but not for capping or for serine/threonine-kinase recruitment.

Authors:  G T Williams; C J Peaker; K J Patel; M S Neuberger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  B cells extract and present immobilized antigen: implications for affinity discrimination.

Authors:  F D Batista; M S Neuberger
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

Review 8.  Role of the BCR complex in B cell development, activation, and leukemic transformation.

Authors:  Susan R Rheingold; Valerie I Brown; Junjie Fang; Jenny M Kim; Stephan A Grupp
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum.

Authors:  Wolfgang W A Schamel; Stephan Kuppig; Bernd Becker; Kerstin Gimborn; Hans-Peter Hauri; Michael Reth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

10.  Antigen-specific B lymphocytes acquire proteoglycan aggrecan from cartilage extracellular matrix resulting in antigen presentation and CD4+ T-cell activation.

Authors:  Marzena Ciechomska; Caroline L Wilson; Achilleas Floudas; Wang Hui; Andrew D Rowan; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.